{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:09:30Z","timestamp":1782860970346,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.addbeh.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,8,17]],"date-time":"2013-08-17T06:17:29Z","timestamp":1376720249000},"page":"2868-2873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland"],"prefix":"10.1016","volume":"38","author":[{"given":"Becky L.","family":"Genberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirinda","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris-Ellyn","family":"Johanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquie","family":"Astemborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory D.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vlahov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.addbeh.2013.08.008_bb0005","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1080\/10550490490440780","article-title":"French field experience with buprenorphine","volume":"13","author":"Auriacombe","year":"2004","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0015","series-title":"Drug treatment in Baltimore: 2005","author":"Baltimore Substance Abuse Systems, Baltimore City Health Department","year":"2006"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0010","series-title":"The Baltimore buprenorphine initiative: Second interim progress report, June 2008","author":"Baltimore Substance Abuse Systems, Baltimore City Health Department","year":"2008"},{"issue":"3","key":"10.1016\/j.addbeh.2013.08.008_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"9","key":"10.1016\/j.addbeh.2013.08.008_bb0025","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1360-0443.2010.03014.x","article-title":"The global diversion of pharmaceutical drugs: Opiate treatment and the diversion of pharmaceutical opiates: A clinician's perspective","volume":"105","author":"Bell","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.addbeh.2013.08.008_bb0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11524-007-9248-5","article-title":"Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002","volume":"85","author":"Brady","year":"2008","journal-title":"Journal of Urban Health: Bulletin of the New York Academy of Medicine"},{"issue":"17","key":"10.1016\/j.addbeh.2013.08.008_bb0040","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200510273531724","article-title":"Potential for abuse of buprenorphine in office-based treatment of opioid dependence","volume":"353","author":"Cicero","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.addbeh.2013.08.008_bb0045","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1526-4637.2010.00877.x","article-title":"Post-marketing surveillance of methadone and buprenorphine in the United States","volume":"11","author":"Dasgupta","year":"2010","journal-title":"Pain Medicine"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2007.08.008","article-title":"Prescription opioid use, misuse, and diversion among street drug users in New York City","volume":"92","author":"Davis","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0055","series-title":"Title XXXV, section 3502","author":"Drug Addiction Treatment Act of 2000 (DATA)","year":"2000"},{"issue":"2","key":"10.1016\/j.addbeh.2013.08.008_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550490701860971","article-title":"Long-term treatment with buprenorphine\/naloxone in primary care: Results at 2-5years","volume":"17","author":"Fiellin","year":"2008","journal-title":"The American Journal on Addictions"},{"issue":"3","key":"10.1016\/j.addbeh.2013.08.008_bb0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/jurban\/jth125","article-title":"Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users","volume":"81","author":"Friedman","year":"2004","journal-title":"Journal of Urban Health: Bulletin of the New York Academy of Medicine"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"10","author":"Fudala","year":"2003","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.addbeh.2013.08.008_bb0075","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/aje\/kwg209","article-title":"Longitudinal patterns of drug injection behavior in the ALIVE study cohort,1988\u20132000: Description and determinants","volume":"158","author":"Galai","year":"2003","journal-title":"American Journal of Epidemiology"},{"issue":"7","key":"10.1016\/j.addbeh.2013.08.008_bb0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/aje\/kwq441","article-title":"Trajectories of injection drug use over 20years (1988\u20132008) in Baltimore, Maryland","volume":"173","author":"Genberg","year":"2011","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1016\/j.addbeh.2013.08.008_bb0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Gwin Mitchell","year":"2009","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0090","series-title":"Diversion and abuse of buprenorphine: A brief assessment of emerging indicators, final report","author":"JBS International","year":"2006"},{"issue":"1\u20133","key":"10.1016\/j.addbeh.2013.08.008_bb0095","first-page":"190","article-title":"Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians","volume":"120","author":"Johanson","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"18","key":"10.1016\/j.addbeh.2013.08.008_bb0100","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"The New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.addbeh.2013.08.008_bb0105","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA: The Journal of the American Medical Association"},{"issue":"8","key":"10.1016\/j.addbeh.2013.08.008_bb0115","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1360-0443.1998.93811917.x","article-title":"Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users","volume":"93","author":"Latkin","year":"1998","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.addbeh.2013.08.008_bb0110","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1360-0443.1993.tb02058.x","article-title":"Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users","volume":"88","author":"Latkin","year":"1993","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.addbeh.2013.08.008_bb0120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.addbeh.2013.08.008_bb0125","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1360-0443.2003.00335.x","article-title":"Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.addbeh.2013.08.008_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(88)90053-1","article-title":"Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys","volume":"21","author":"Mello","year":"1988","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0376-8716(85)90062-6","article-title":"Behavioral pharmacology of buprenorphine","volume":"14","author":"Mello","year":"1985","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.addbeh.2013.08.008_bb0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10550880903014767","article-title":"Diversion of buprenorphine\/naloxone coformulated tablets in a region with high prescribing prevalence","volume":"28","author":"Monte","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0145","series-title":"Intoxication deaths associated with drugs of abuse or alcohol","author":"Office of Epidemiology and Planning, Baltimore City Health Department","year":"2007"},{"issue":"8","key":"10.1016\/j.addbeh.2013.08.008_bb0150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1360-0443.2004.00790.x","article-title":"A critical review of the causes of death among post-mortem toxicological investigations: Analysis of 34 buprenorphine-associated and 35 methadone-associated deaths","volume":"99","author":"Pirnay","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0155","series-title":"The Baltimore Sun","article-title":"The \u2018bupe\u2019 fix","author":"Schulte","year":"2007"},{"issue":"1","key":"10.1016\/j.addbeh.2013.08.008_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: Illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.addbeh.2013.08.008_bb0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988\u20132000","volume":"83","author":"Shah","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.addbeh.2013.08.008_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1300\/J069v26n03_12","article-title":"Abuse of buprenorphine in the United States: 2003\u20132005","volume":"26","author":"Smith","year":"2007","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.addbeh.2013.08.008_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.addbeh.2013.08.008_bb0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2013.08.008_bb0185","first-page":"75","article-title":"The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants","volume":"109","author":"Vlahov","year":"1991","journal-title":"NIDA Research Monograph"},{"issue":"Suppl. 1","key":"10.1016\/j.addbeh.2013.08.008_bb0190","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1360-0443.2007.01767.x","article-title":"Risk factors for methadone outside treatment programs: Implications for HIV treatment among injection drug users","volume":"102","author":"Vlahov","year":"2007","journal-title":"Addiction"},{"issue":"2 Suppl","key":"10.1016\/j.addbeh.2013.08.008_bb0205","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0376-8716(03)00056-5","article-title":"The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic","volume":"70","author":"Walsh","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2013.08.008_bb0195","first-page":"361","article-title":"Acute administration of buprenorphine in humans: Partial agonist and blockade effects","volume":"274","author":"Walsh","year":"1995","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.addbeh.2013.08.008_bb0200","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology and Therapeutics"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460313002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460313002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T21:56:55Z","timestamp":1539467815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460313002232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0306460313002232"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2013.08.008","relation":{},"ISSN":["0306-4603"],"issn-type":[{"value":"0306-4603","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}